Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Crohn's disease can cause hair loss before other symptoms appear.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Women with AGA have higher lipid levels, increasing heart disease risk.

Non-obese women with hair loss have higher heart disease risk.

Human hair protein modifications could potentially indicate heart disease risk.

Medications for PCOS don't seem to raise heart disease risk.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.